FIGURE 2.

Bone‐related parameters measured in OI patients before, during, and after the MSCs therapy. (A and B) Number of fractures in TERCELOI patients before the cell therapy: during the perinatal period, childhood (from perinatal period up to 5‐year old in P01 and up to 7‐year old in P02), and the year previous the first infusion of MSCs; during the cell therapy treatment (each of the five MSCs infusion is depicted) and during the follow‐up visits (1 and 2 years after the fifth MSCs infusion); 1 w (1 week), 1 m (1 month), and 4 m (4 months) indicate the visits after each cell infusion. (C) BMD of P01 (blue line) and P02 (orange line) before (0 months), during (MSCs infusions are specified with arrows), and after the cell therapy